Search for a clinical trial
Other search option(s)
9 Result(s)
Recruiting trial
= ; Ongoing trial
=
; Terminated trial =
; Funded by an IRDiRC member =
; Member of a ERN =
National clinical trial(s)

AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT


TALAPRO-1: A phase 2, open-label, response rate study of talazoparib in men with DNA repair defects metastatic castration-resistant prostate cancer who previously received taxane-based chemotherapy and progressed on at least 1 novel hormonal agent (enzalutamide and/or abiraterone acetate/prednisone) - AT
Institution: Information not provided - AT

BELGIUM
VLAAMS BRABANT
LEUVEN


OLE-IEDAT: Open-label, Long-term, Extension Treatment using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients with Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 Study - BE
UZ Leuven - Campus Gasthuisberg
Laboratory of Pediatric Immunology

GERMANY
Berlin
ADDRESS: NOT PROVIDED - DE

Open-label, Long-term, Extension Treatment using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients with Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 Study -DE-
Institution: Information not provided - DE

GERMANY
Hessen
FRANKFURT AM MAIN


OLE-IEDAT: Open-label, Long-term, Extension Treatment using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients with Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 Study -DE-
Universitätsklinikum Frankfurt
Schwerpunkt Allergologie, Pneumologie und Mukoviszidose

SPAIN
Madrid
MADRID


OLE-IEDAT: Open-label, Long-term, Extension Treatment using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients with Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 Study - ES
Hospital Universitario La Paz
Servicio de Neurología

SPAIN
Madrid
MADRID

Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A multinational, multicenter, open-label, rater-blinded Phase II study -ES
Hospital Universitario La Paz
Servicio de Neurología infantil

ITALY
LAZIO
ROMA
Effect of riluzole as a symptomatic approach in patients with chronic cerebellar ataxia
A.O. S. Andrea
U.O.C. di Neurologia
Multinational clinical trial(s)

ITALY
EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
OLE-IEDAT: Open-label, Long-term, Extension Treatment using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients with Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 Study
Institution: Information not provided - IT

UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US